| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |